Enoxaparin sodium biosimilar (Sahar International Trading)

依诺肝素钠生物类似药 (Sahar International Trading)

Report date: 2022/01/14 13:23:58

Base Information

Drug NameEnoxaparin sodium biosimilar (Sahar International Trading)
Drug Alias Name依诺肝素钠生物仿制药 (Sahar International Trading)
ClassificationBiologics > Biosimilar
Mechanisms of ActionAntithrombin-III activatorsFactor Xa inactivationThrombin inactivation
TargetsAntithrombin-IIIProthrombinCoagulation factor X
Therapy Area/IndicationsBlood Coagulation DisordersVenous ThromboembolismST Elevation Myocardial Infarction +[4] 
Global Approved IndicationsBlood Coagulation DisordersVenous ThromboembolismST Elevation Myocardial Infarction +[4] 
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved Date2013/07/01
Country/TerritoryN/A
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesSahar International Trading
China Registration ClassN/A

Develop Information

Active CompaniesSahar International Trading
Inactive CompaniesN/A
Active IndicationsBlood Coagulation DisordersVenous ThromboembolismST Elevation Myocardial Infarction +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeB01AB05
Related LinksN/A